15
AAVMC study shows most veterinary grads quick to find jobs According to the Association of American Veterinary Medicine Colleges (AAVMC), new veterinary medicine graduates don’t appear to be struggling as hard to find employment as some recent news articles have reported. The AAVMC released results of its survey asking 2011 and
2012 graduates about their employment status following graduation. According to the AAVMC, the results overwhelm- ingly showed that the majority of veterinary medicine students have successfully found employment during the year follow- ing graduation. According to the AAVMC, 98.4% of 2011 graduates and
97.7% of 2012 graduates reported they are employed at least 6 months after graduating. Dr. Deborah Kochevar, AAVMC president, said in an open
letter to the veterinary medical community that the study results contradict a February New York Times article that she said painted a “bleak picture” regard- ing the economic issues facing today’s veterinary students and new graduates. Kochevar pointed out in her letter that the employment numbers are impressive by any standard, especially when compared to the nation’s unemployment rate.
UGA researchers working on promising rabies vaccine University of Georgia research- ers reported that their new rabies vaccine is producing impressive results in clinical trials so far. According to the article in
bodies to the rabies virus, which encourages production of anti- bodies that will defend against rabies infection in the future. UGA researchers tested the
UGA Today, researchers created the vaccine by inserting a non- viral piece of the rabies virus into parainfluenza virus 5. This genetic engineering approach exposes human and animal
vaccine in mice by administer- ing the vaccine orally, nasally, or by intramuscular injection, then giving the mice a lethal dose of the rabies virus. They observed a 50% survival rate for mice that had received the vaccine
Promising study for those with cat allergies Allergies may soon cease to be a barrier to cat adoption for mil- lions of people who suffer from sneezing, itching, and watery eyes whenever they get close to fur-covered felines. Researchers testing the efficacy of a new cat-allergy treatment
called Cat-peptide antigen desensitization (Cat-PAD) recently released promising results, saying the treatment has provided long- lasting allergy relief for study participants, according to McMas- ter University. During the phase II clinical study, a total of 202 participants
were either given a placebo or four injections of Cat-PAD over the course of 12 weeks. According to researchers, participants who were given Cat-PAD
often experienced “substantial” relief from their allergy symptoms that lasted throughout the entire 2-year time period following the injections, the university reported.
orally, compared with 100% for mice that received the vaccine nasally or intramuscularly. Researchers have indicated
that subsequent canine tests have shown promising results, UGA Today reported. They estimated the vaccine could be available on the market for animals in 3 to 5 years, but humans will likely have to wait longer.
Trends magazine, May 2013
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60